Alvaro D. Facta
University of California, Los Angeles
11 Papers
64 Citations
Alvaro D. Facta is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Type 2 Diabetes Mellitus & Internal medicine. The author has an hindex of 9, co-authored 11 publications.
Chat about Author
Papers
Coronary Circulatory Dysfunction in Insulin Resistance, Impaired Glucose Tolerance, and Type 2 Diabetes Mellitus
John O. Prior,Manuel J. Quiñones,Miguel Hernandez-Pampaloni,Alvaro D. Facta,Thomas H. Schindler,James Sayre,Willa A. Hsueh,Heinrich R. Schelbert +7 more
TL;DR: Progressively worsening functional coronary circulatory abnormalities of nitric oxide–mediated, endothelium-dependent vasomotion occur with increasing severity of insulin-resistance and carbohydrate intolerance.
284
PET-Measured Responses of MBF to Cold Pressor Testing Correlate with Indices of Coronary Vasomotion on Quantitative Coronary Angiography
Thomas H. Schindler,Egbert U. Nitzsche,Manfred Olschewski,Ingo Brink,Michael Mix,John O. Prior,Alvaro D. Facta,Massayuki Inubushi,Hanjoerg Just,Heinrich R. Schelbert +9 more
TL;DR: The observed close correlation between an angiographically established parameter of flow-dependent and, most likely, endothelium-mediated coronary vasomotion and PET-measured MBF further supports the validity and value of MBF responses to CPT as a noninvasively available index of coronary circulatory function.
86
Improvement in coronary endothelial function is independently associated with a slowed progression of coronary artery calcification in type 2 diabetes mellitus.
Thomas H. Schindler,Jerson Cadenas,Alvaro D. Facta,Yanjie Li,Manfred Olschewski,James Sayre,Jonathan G. Goldin,Heinrich R. Schelbert +7 more
TL;DR: In DM, glucose-lowering treatment may beneficially affect structure and function of the vascular wall, whereas the observed improvement in endothelium-related coronary artery function may also mediate direct preventive effects on the progression of CAC.
55
Myocardial viability in patients with ischemic cardiomyopathy-evaluation by 3-D integration of myocardial scintigraphic data--and coronary angiographic data.
Thomas H. Schindler,Egbert U. Nitzsche,Egbert U. Nitzsche,Nobuhisa Magosaki,Michael Mix,Alvaro D. Facta,John O. Prior,Ulrich Solzbach,Heinrich R. Schelbert,Hanjoerg Just +9 more
TL;DR: In patients with end-stage coronary artery disease scintigraphic imaging is most important in the decision-making process, three-dimensional fusion imaging may add important information in approximately 30% of these patients.
7